Hyderabad: Biological E. Limited (BE), a Hyderabad-based vaccine and pharmaceutical company, has announced reduction in the price of its COVID-19 Vaccine Corbevax from Rs. 840 to Rs.250 a dose inclusive of GST, for Private COVID-19 vaccination centres. For the end user, the price would be Rs 400 a dose, including taxes and administration charges. The […]
Hyderabad: Optimus, which has completed molnupiravir oral capsule phase 3 clinical trial, has applied for emergency use authorization (EUA) for the drug with the Drugs Controller General of India (DCGI). On May 18, 2021, the Hyderabad-based company received approval from the DCGI to conduct the phase 3 trial as per the recommendations of the […]
Hyderabad-based pharma company has approached the Drug Controller General of India to seek Emergency Use Authorization for the investigational drug in India
With herd immunity and a significant percentage of the US population vaccinated, the pandemic is reducing, and keeping this in view, the USFDA communicated that no new emergency use authorization would be approved for new Covid-19 vaccines